Add-on prolonged-release melatonin for cognitive function and sleep in mild to moderate Alzheimer’s disease: a 6-month, randomized, placebo-controlled, multicenter trial

PURPOSE: A link between poor sleep quality and Alzheimer’s disease (AD) has recently been suggested. Since endogenous melatonin levels are already reduced at preclinical AD stages, it is important to ask whether replenishing the missing hormone would be beneficial in AD and whether any such effects...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Autori principali: Wade, Alan G, Farmer, Mildred, Harari, Gil, Fund, Naama, Laudon, Moshe, Nir, Tali, Frydman-Marom, Anat, Zisapel, Nava
Natura: Artigo
Lingua:Inglês
Pubblicazione: Dove Medical Press 2014
Soggetti:
Original Research
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC4069047/
https://ncbi.nlm.nih.gov/pubmed/24971004
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/CIA.S65625
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi